302 related articles for article (PubMed ID: 33109613)
21. Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor.
Faheem M; Rehman MT; Danishuddin M; Khan AU
PLoS One; 2013; 8(2):e56926. PubMed ID: 23437273
[TBL] [Abstract][Full Text] [Related]
22. Understanding the molecular determinants of substrate and inhibitor specificities in the Carbapenemase KPC-2: exploring the roles of Arg220 and Glu276.
Papp-Wallace KM; Taracila MA; Smith KM; Xu Y; Bonomo RA
Antimicrob Agents Chemother; 2012 Aug; 56(8):4428-38. PubMed ID: 22687511
[TBL] [Abstract][Full Text] [Related]
23. Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene.
Vakulenko SB; Geryk B; Kotra LP; Mobashery S; Lerner SA
Antimicrob Agents Chemother; 1998 Jul; 42(7):1542-8. PubMed ID: 9660980
[TBL] [Abstract][Full Text] [Related]
24. Crystallographic Snapshots of Class A β-Lactamase Catalysis Reveal Structural Changes That Facilitate β-Lactam Hydrolysis.
Pan X; He Y; Lei J; Huang X; Zhao Y
J Biol Chem; 2017 Mar; 292(10):4022-4033. PubMed ID: 28100776
[TBL] [Abstract][Full Text] [Related]
25. Structural Insight into the Mechanism of Inhibitor Resistance in CTX-M-199, a CTX-M-64 Variant Carrying the S
Cheng Q; Xu C; Chai J; Zhang R; Wai Chi Chan E; Chen S
ACS Infect Dis; 2020 Apr; 6(4):577-587. PubMed ID: 31709791
[TBL] [Abstract][Full Text] [Related]
26. Structural and biochemical evidence that a TEM-1 beta-lactamase N170G active site mutant acts via substrate-assisted catalysis.
Brown NG; Shanker S; Prasad BV; Palzkill T
J Biol Chem; 2009 Nov; 284(48):33703-12. PubMed ID: 19812041
[TBL] [Abstract][Full Text] [Related]
27. Nacubactam Enhances Meropenem Activity against Carbapenem-Resistant Klebsiella pneumoniae Producing KPC.
Barnes MD; Taracila MA; Good CE; Bajaksouzian S; Rojas LJ; van Duin D; Kreiswirth BN; Jacobs MR; Haldimann A; Papp-Wallace KM; Bonomo RA
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182530
[TBL] [Abstract][Full Text] [Related]
28. CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate.
Shen Z; Ding B; Bi Y; Wu S; Xu S; Xu X; Guo Q; Wang M
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821452
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic study of resistance of beta-lactamase-inhibitor-resistant TEM enzymes which differ by naturally occurring variations and by site-directed substitution at Asp276.
Caniça MM; Caroff N; Barthélémy M; Labia R; Krishnamoorthy R; Paul G; Dupret JM
Antimicrob Agents Chemother; 1998 Jun; 42(6):1323-8. PubMed ID: 9624468
[TBL] [Abstract][Full Text] [Related]
30. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
[TBL] [Abstract][Full Text] [Related]
31. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
[TBL] [Abstract][Full Text] [Related]
32. Role of Asp104 in the SHV beta-lactamase.
Bethel CR; Hujer AM; Hujer KM; Thomson JM; Ruszczycky MW; Anderson VE; Pusztai-Carey M; Taracila M; Helfand MS; Bonomo RA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4124-31. PubMed ID: 16982784
[TBL] [Abstract][Full Text] [Related]
33. Mutation of the active site carboxy-lysine (K70) of OXA-1 beta-lactamase results in a deacylation-deficient enzyme.
Schneider KD; Bethel CR; Distler AM; Hujer AM; Bonomo RA; Leonard DA
Biochemistry; 2009 Jul; 48(26):6136-45. PubMed ID: 19485421
[TBL] [Abstract][Full Text] [Related]
34. Elucidating the role of Trp105 in the KPC-2 β-lactamase.
Papp-Wallace KM; Taracila M; Wallace CJ; Hujer KM; Bethel CR; Hornick JM; Bonomo RA
Protein Sci; 2010 Sep; 19(9):1714-27. PubMed ID: 20662006
[TBL] [Abstract][Full Text] [Related]
35. Role of asparagine 152 in catalysis of beta-lactam hydrolysis by Escherichia coli AmpC beta-lactamase studied by site-directed mutagenesis.
Dubus A; Normark S; Kania M; Page MG
Biochemistry; 1995 Jun; 34(23):7757-64. PubMed ID: 7779822
[TBL] [Abstract][Full Text] [Related]
36. A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation.
Sideraki V; Huang W; Palzkill T; Gilbert HF
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):283-8. PubMed ID: 11114163
[TBL] [Abstract][Full Text] [Related]
37. Multiple substitutions at position 104 of beta-lactamase TEM-1: assessing the role of this residue in substrate specificity.
Petit A; Maveyraud L; Lenfant F; Samama JP; Labia R; Masson JM
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):33-40. PubMed ID: 7826350
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
Kumar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
[TBL] [Abstract][Full Text] [Related]
39. Exploring sequence requirements for C₃/C₄ carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase.
Drawz SM; Taracila M; Caselli E; Prati F; Bonomo RA
Protein Sci; 2011 Jun; 20(6):941-58. PubMed ID: 21404358
[TBL] [Abstract][Full Text] [Related]
40. Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.
Ishii Y; Ohno A; Taguchi H; Imajo S; Ishiguro M; Matsuzawa H
Antimicrob Agents Chemother; 1995 Oct; 39(10):2269-75. PubMed ID: 8619581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
